In conclusion, this study identified vWAT as an important player in the onset of metabolic complications typical of FA and suggests butyrate as safe and promising adjuvant tool to treat metabolic complications in FA.
Sunday, April 9, 2023
Butyrate prevents visceral adipose tissue inflammation and metabolic alterations in a mouse model of Friedreich's ataxia
TURCHI R, SCIARRETTA F, TIBERI M, et al. Butyrate prevents visceral adipose tissue inflammation and metabolic alterations in a mouse model of Friedreich's ataxia. bioRxiv; 2023. DOI: 10.1101/2023.04.06.535845.
